Mehta Sameer K, Sunder Ashok
Department of Medicine, Tata Main Hospital, Jamshedpur, Jharkhand, India.
J Family Med Prim Care. 2021 Jul;10(7):2706-2708. doi: 10.4103/jfmpc.jfmpc_2454_20. Epub 2021 Jul 30.
Neurological involvement after coronavirus disease (COVID-19) pneumonias is common and occurs in almost one-third of the patients. The commonest neurological symptoms are ageusia, anosmia, headache, nausea, vomiting, dizziness, and myalgia. Guillain-Barre syndrome (GBS) is a rare manifestation of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection; whereas the common neurological manifestations of the SARS-CoV-2 infection occur with the onset of the respiratory symptoms and may be due to the direct invasion of the nervous system by the virus, GBS in COVID-19 follows a time lag of 1-4 weeks and may be attributable to the immune mechanism of molecular mimicry. Here we report a case of GBS in a patient of COVID-19 which occurred on the 22 day after the onset of the disease. The patient recovered completely and went home walking.
冠状病毒病（COVID-19）肺炎后的神经系统受累很常见，几乎三分之一的患者会出现。最常见的神经系统症状是味觉丧失、嗅觉丧失、头痛、恶心、呕吐、头晕和肌痛。吉兰-巴雷综合征（GBS）是严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染的罕见表现；SARS-CoV-2感染的常见神经系统表现随着呼吸道症状的出现而发生，可能是由于病毒直接侵袭神经系统所致，而COVID-19中的GBS在发病后1至4周出现，可能归因于分子模拟的免疫机制。在此，我们报告1例COVID-19患者发生GBS的病例，该病例在疾病发作后第22天出现。患者完全康复，步行回家。
